Skip to main content
. 2023 Feb 13;15(2):621. doi: 10.3390/pharmaceutics15020621

Table 2.

Summary of cancer-cell-membrane-coated nanoparticles for ND drug delivery.

Drug Targeted Delivery System Cancer Cell Membrane Targeted Modification Materials of NPs Drug-Loading Cancer Model Reference
CCNP MDA-MB-831cells No mPEG-PLGA-NPs Doxorubicin (DOX) Brain and metastatic breast cancer [82]
CM-NCubes U-251 MG cells No Fe3O4/MnO2- NCubes Sorafenib and AMF GBM [88]
Dox-CM-BNNTs U87 MG cells No BNNTs DOX GBM [89]
DHA-NGR/CCNLC C6 glioma cells NGR NLCs DHA Glioma [81]
WSW-CCM-(PTX)NS C6 glioma cells DWSW PVP K30 and SDC nanosuspension Paclitaxel (PTX) Glioma [87]
HCPT-NS/CCM C6 glioma cells No Nanosuspension 10-hydroxycamptothecin (HCPT) Glioma [80]
MnO2-DOX-C6 C6 glioma cells No MnO2 Doxorubicin (DOX) Glioma [85]
HDX@YSN@CCM@cRGD U87 MG cells cRGD YSNs Hydroxychloroquine (HDX) Glioblastoma [86]
CC-LnNPs U87 MG cells No LnNPs No Glioma [90]